期刊文献+

妊娠滋养细胞疾病中EMT相关蛋白CK-18、波形蛋白的表达及意义 被引量:5

The Expression of EMT Associated Protein CK-18 and Vimentin in Gestational Trophoblastic Disease
原文传递
导出
摘要 目的检测上皮细胞间质细胞转化(EMT)相关蛋白——细胞角蛋白18(CK-18)和波形蛋白(vimentin)在正常早孕绒毛、葡萄胎及妊娠滋养细胞肿瘤中的表达及与临床病理特征的关系。方法采用免疫组化法(SP法)检测39例正常早孕绒毛组织、33例葡萄胎组织和32例妊娠滋养细胞肿瘤组织(侵袭性葡萄胎27例、绒毛膜癌5例)中CK-18、vimentin的定位及表达情况。结果 CK-18在各种类型滋养细胞中呈强阳性表达,正常绒毛组的CK-18表达水平高于葡萄胎组及妊娠滋养细胞肿瘤组,差异有统计学意义(P<0.01),葡萄胎组CK-18表达高于滋养细胞肿瘤组,差异有统计学意义(P<0.01);vimentin于各组滋养细胞中呈弱阳性表达,各组间的表达差异无统计学意义(P>0.05)。在葡萄胎滋养细胞轻度增生组,CK-18蛋白的相对表达量高于滋养细胞中或重度增生组(P<0.01)。在滋养细胞肿瘤解剖学Ⅰ期组CK-18蛋白的相对表达量高于解剖学Ⅱ期及以上组(P<0.001)。结论伴随着滋养细胞恶性度的升高CK-18的表达逐渐降低,提示EMT可能与滋养细胞的恶性转化有相关性。 Objective To analyze the expression and clinicopathologic features of epithelial to mesenchymal transition(EMT)associated protein of cytokeratin-18(CK-18)and vimentin in gestational trophoblastic disease(GTD).Methods Immunohistochemistry was used to determine theexpression of CK-18 and vimentin in normal pregnancy villis(39cases),hydatidiform mole(HM)(33cases)and gestational trophoblastic neoplasia(GTN)(invasive mole 27 cases and choriocarcinoma 5cases).Results The GTN group had significantly lower levels of CK-18 compared with the normal pregnancy villis group and the HM group(P〈0.01).Vimentin was weakly positive in all kinds of trophocyte.There was no significance among normal pregnancy villis,HM and GTN groups(P〉0.05).In HM,expression level of CK18 was significantly lower with the increase of the pathological malignancy(P〈0.01).And in GTN,the expression of CK-18 was significantly lower with the increase of the tumor anatomy stage(P〈0.001).Conclusion The expression of CK-18 decreases with the increase of tropohblast malignancy,which indicates that CK-18 may be involved in malignant transformation of trophocytes and EMT may play an important role in the malignant transformation of GTN.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2014年第6期960-963,1014,共5页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(No.81174289)资助
  • 相关文献

参考文献14

  • 1Seckl MJ,Sebire NJ,Berkowitz RS.Gestational trophoblastic disease.Lancet,2010;376(9742):717-729.
  • 2Tomizaw SI,Sasaki H.Genomic imprinting and its relevance to congenital disease,infertility,molar pregnancy and induced pluripotent stem cell.J Hum Genet,2012;57(2):84-91.
  • 3Willipinski-Stapelfeldt B,Riethdorf S,Assmann V,et al.Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.Clin Cancer Res,2005;11(22):8006-8014.
  • 4Thiery JP,Acloque H,Huang RY,et al.Epithelialmesenchymal transitions in development and disease.Cell,2009;139(5):871-890.
  • 5Arinoto-Ishida E,Sakata M,Sawada K,et al.Up-regulation of alpha(5)-integrin by E-cadherin loss in hypoxia and its key role in the migration of extravillous trophoblast cells during early implantation.Endocrinology,2009;150(9):4306-4315.
  • 6Chu PG,Weiss LM.Keratin expression in human tissues and neoplasms.Histopathology,2002;40(5):403-439.
  • 7Satelli A,Li S.Vimentin in cancer and its potential as a molecular target for cancer therapy.Cell Mol Life Sci,2011;68(18):3033-3046.
  • 8Kalluri R,Weinberg RA.The basics of epithelial-mesenchymal transition.J Clin Invest,2009;119(6):1420-1428.
  • 9张烨,薛艳,刘腾,张勇华,安瑞芳.妊娠滋养细胞肿瘤291例临床特征分析[J].实用妇产科杂志,2012,28(11):981-984. 被引量:8
  • 10Ausch C,Buxhofer-Ausch V,OlszewskiL U,et al.Circulating cytokeratin 18fragments and activation of dormant tumor cells in bone marrow of cancer patients.Exp Ther Med,2010;1(1):9-12.

二级参考文献8

共引文献7

同被引文献48

  • 1丰有吉.妇产科学[M].第2版.北京:人民卫生出版社,2010:68-69.
  • 2云海霞.绒毛膜癌患者化疗的护理体会[J].I晦床护理,2012,10(29):240-241.
  • 3NGAN H Y,KOHOM E I,COLE L A,et al.Throphoblastic disease[Z],2012:S130-S136.
  • 4ALAZZAM M,TIDY J,OSBOME R,et al.Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia[Z],2012:CD008891.
  • 5NGAN H Y.The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia[J].International Journal of Gynecological Cancer:Official Journal of the International Gynecological Cancer Society,2004,14(2):202-205.
  • 6NGU S F,CHAN K K.Management of chemoresistant and quiescent gestational trophoblastic disease[J].Current Obstetrics and Gynecology Reports,2014,3:84-90.
  • 7Feng F.Xiang Y.Wan X.et al.Salvage combination chemotherapy with floxuridine,dactinomycin,etoposide,and vincristine(FAEV)for patients with relapsed/chemoresistant gestational trophoblastic neoplasia[J].Ann Oncol,2011,22:1588-1594.
  • 8MCNEISH I A,STRICKLAND S,HOLDEN L,et al.Low-risk persistent gestational trophoblastic disease:outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to2000[J].Journal of Clinical Oncology:Official Journal of the American Society of Clinical Oncology,2002,20(7):1838-1844.
  • 9SEBIRE N J,SECKL M J.Gestational trophobastic disease:current management of hydatidiform mole[Z].2008:A1193.
  • 10TAYLOR F,GREW T,EVERARD J,et al.The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid[J].European Journal of Cancer(Oxford,England:1990),2013,49(15):3184-3190.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部